Archive for Werewolf

Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on its WTX-124 INDUKINE™ Program

August 19, 2021

Werewolf Therapeutics Announces Its Addition to the Russell 2000® Index

June 24, 2021

Werewolf Therapeutics Howls onto the Nasdaq with $120M IPO

April 30, 2021

Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering

April 30, 2021

Werewolf Joins Pack of Newly Public Biotechs with Upsized $120M IPO

April 30, 2021

Werewolf Therapeutics looks to make a killing in the public markets with a $100M IPO

April 12, 2021